Transcriptional analysis of prebiotic uptake and catabolism by Lactobacillus acidophilus NCFM
- PMID: 23028535
- PMCID: PMC3446993
- DOI: 10.1371/journal.pone.0044409
Transcriptional analysis of prebiotic uptake and catabolism by Lactobacillus acidophilus NCFM
Abstract
The human gastrointestinal tract can be positively modulated by dietary supplementation of probiotic bacteria in combination with prebiotic carbohydrates. Here differential transcriptomics and functional genomics were used to identify genes in Lactobacillus acidophilus NCFM involved in the uptake and catabolism of 11 potential prebiotic compounds consisting of α- and β-linked galactosides and glucosides. These oligosaccharides induced genes encoding phosphoenolpyruvate-dependent sugar phosphotransferase systems (PTS), galactoside pentose hexuronide (GPH) permease, and ATP-binding cassette (ABC) transporters. PTS systems were upregulated primarily by di- and tri-saccharides such as cellobiose, isomaltose, isomaltulose, panose and gentiobiose, while ABC transporters were upregulated by raffinose, Polydextrose, and stachyose. A single GPH transporter was induced by lactitol and galactooligosaccharides (GOS). The various transporters were associated with a number of glycoside hydrolases from families 1, 2, 4, 13, 32, 36, 42, and 65, involved in the catabolism of various α- and β-linked glucosides and galactosides. Further subfamily specialization was also observed for different PTS-associated GH1 6-phospho-β-glucosidases implicated in the catabolism of gentiobiose and cellobiose. These findings highlight the broad oligosaccharide metabolic repertoire of L. acidophilus NCFM and establish a platform for selection and screening of both probiotic bacteria and prebiotic compounds that may positively influence the gastrointestinal microbiota.
Conflict of interest statement
Figures




References
-
- Tang ML, Lahtinen SJ, Boyle RJ (2010) Probiotics and prebiotics: Clinical effects in allergic disease. Curr Opin Pediatr 22: 626–634. - PubMed
-
- Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, et al. (2012) The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 14: 112–120. - PubMed
-
- Scarpellini E, Campanale M, Leone D, Purchiaroni F, Vitale G, et al. (2010) Gut microbiota and obesity. Intern Emerg Med 5 Suppl 1: S53–6. - PubMed
-
- Hedin C, Whelan K, Lindsay JO (2007) Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: A review of clinical trials. Proc Nutr Soc 66: 307–315. - PubMed
-
- Reid G, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, et al. (2003) New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 37: 105–118. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Molecular Biology Databases